Cognyte heads into its next report carrying a narrative that sounds better than its cash flow statement looked last quarter, and this release should tell investors which one is the more accurate signal. Wall Street expects revenue of $108.7 million, up 11.5% year over year, alongside GAAP earnings of just $0.01 per share, a steep drop from the $0.03 posted in the same quarter last year. That EPS figure is not the headline metric here. The real test is whether the operational trends management flagged last quarter are continuing to build or starting to crack.
The prior call laid out a clear thesis. Recurring revenue was supposed to become the growth engine, guided to exceed 12% growth for the fiscal year and outpace total revenue after landing at 10% growth in the first quarter. Billings had accelerated sharply, up 31.2% year over year, and management pointed to a new three-year subscription deal worth over $20 million plus a follow-on expansion above $10 million as proof the subscription shift was becoming a durable pattern rather than a one-off. The US business was quantified for the first time at roughly $20 million of expected deals this year, with management describing rising confidence and even hinting at upside. This report needs to show that recurring revenue growth is holding above that 12% bar and that billings momentum has not stalled, because those are the two data points that would validate the pivot from a services-heavy, lumpy business to a more predictable one.
The cracks worth watching are just as important. Total remaining performance obligations fell for a third straight quarter to $528.8 million, down from $576.6 million two quarters earlier, and free cash flow turned negative $6.1 million as a $3 million inventory build against rising hardware costs ate into cash generation. Management held its $45 million full-year cash flow guide but admitted it is now more back-end loaded, which puts real pressure on the back half to deliver. The FY28 adjusted EBITDA margin target was also trimmed to approximately 20% from over 20%, blamed on shekel strength against the dollar. None of these are fatal on their own, but together they represent the counter-narrative to the recurring-revenue optimism, and this quarter's RPO and cash flow trends will show whether that erosion is stabilizing or continuing.
On the guidance front, the company reaffirmed its fiscal 2027 outlook of roughly $0.47 in non-GAAP EPS on revenue between $434.6 million and $461.4 million, which lines up closely with consensus estimates of $0.48 and $448 million. That is a comfortable, roughly mid-range alignment rather than a Street expectation pushing against either edge of guidance, suggesting analysts are not pricing in a major beat or miss relative to management's own framework. Given that total revenue guidance was only reaffirmed last quarter rather than raised, and software revenue growth implicitly decelerates through the year according to management's own framing, there is little room for another quarter of merely in-line results without raising questions about deceleration.
Sentiment context adds a cautionary note. Bullish sentiment has fallen to 9.4% from 21% heading into the last report, and the stock has dropped 10.3% since then while the S&P 500 gained 0.5%, a swing of nearly 11 percentage points in relative performance. Shares now sit below their 200-day moving average of $8.88, trading closer to the low end of a post-earnings range between $7.78 and $9.63, a much narrower band than the prior quarter's spread between $7.64 and $12.31. That compression suggests the market has grown less willing to extend credit for the recurring-revenue story until it sees the cash flow and RPO trends turn back in Cognyte's favor. The central question for this report is whether billings and recurring revenue keep accelerating enough to offset the RPO decline and cash flow pressure that emerged last quarter, because that balance will determine whether the improving-mix narrative regains credibility or gives way to renewed skepticism about execution.